OFLOXACIN

OFLOXACIN was reported 7317 times

OFLOXACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTERIOR SEGMENT ISCHAEMIA 6 0.3158
1 FIBRIN 9 0.2093
2 LARYNGEAL HAEMATOMA 11 0.1642
3 KERATITIS FUNGAL 32 0.1538
4 TYPE 2 LEPRA REACTION 25 0.1337
5 CONJUNCTIVAL BLEB 6 0.1111
6 PERSISTENT LEFT SUPERIOR VENA CAVA 7 0.0654
7 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0611
8 CORNEAL INFILTRATES 18 0.0573
9 CORNEAL DEPOSITS 38 0.0511
10 DELUSION OF REFERENCE 7 0.0504
11 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 9 0.0495
12 CORNEAL PERFORATION 25 0.0396
13 RENAL NECROSIS 8 0.0367
14 TOXIC ANTERIOR SEGMENT SYNDROME 40 0.0367
15 CORNEAL THINNING 9 0.0350
16 CORNEAL SCAR 17 0.0338
17 CORNEAL GRAFT REJECTION 7 0.0333
18 HYPOPYON 27 0.0326
19 IDIOPATHIC ORBITAL INFLAMMATION 6 0.0312
20 CORNEAL EPITHELIUM DEFECT 16 0.0275
21 BONE METABOLISM DISORDER 8 0.0266
22 RECTAL SPASM 6 0.0260
23 ANTERIOR CHAMBER FLARE 6 0.0258
24 ANTERIOR CHAMBER CELL 18 0.0252
25 PERIORBITAL PAIN 20 0.0236
26 EYE ABSCESS 7 0.0230
27 ANTICOAGULATION DRUG LEVEL INCREASED 7 0.0218
28 CORNEAL EROSION 11 0.0204
29 RETINAL PIGMENT EPITHELIAL TEAR 14 0.0202
30 PROSTATIC PAIN 8 0.0196
31 CORNEAL TRANSPLANT 15 0.0192
32 CORNEAL OEDEMA 42 0.0187
33 GINGIVAL ULCERATION 14 0.0186
34 OTITIS MEDIA CHRONIC 7 0.0167
35 GENERALISED BULLOUS FIXED DRUG ERUPTION 6 0.0161
36 PROTHROMBIN TIME RATIO DECREASED 10 0.0160
37 NASAL TURBINATE HYPERTROPHY 6 0.0159
38 EYELID PAIN 32 0.0157
39 THERAPEUTIC PRODUCT CROSS-REACTIVITY 14 0.0157
40 TENDON PAIN 112 0.0148
41 LAGOPHTHALMOS 6 0.0147
42 TENDON DISCOMFORT 11 0.0146
43 LENTICULAR OPACITIES 6 0.0137
44 PELVIC HAEMATOMA 6 0.0136
45 ANTERIOR CHAMBER INFLAMMATION 8 0.0134
46 NON-CARDIOGENIC PULMONARY OEDEMA 14 0.0132
47 CORNEAL OPACITY 18 0.0132
48 ULCERATIVE KERATITIS 36 0.0131
49 CHRONIC FATIGUE SYNDROME 18 0.0129
50 UPPER AIRWAY OBSTRUCTION 11 0.0124
51 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0123
52 SUDDEN INFANT DEATH SYNDROME 6 0.0122
53 ENDOPHTHALMITIS 73 0.0122
54 EYE ULCER 7 0.0122
55 HYPHAEMA 6 0.0115
56 INTRAOCULAR PRESSURE DECREASED 6 0.0114
57 RETINAL VASCULITIS 12 0.0101
58 PROSTATITIS 30 0.0098
59 OTITIS EXTERNA 12 0.0098
60 VASCULITIS NECROTISING 7 0.0098
61 LARYNGEAL DISORDER 7 0.0097
62 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 10 0.0094
63 BLADDER IRRITATION 6 0.0093
64 VASCULAR PURPURA 13 0.0093
65 CORNEAL DISORDER 20 0.0091
66 TENDON DISORDER 59 0.0090
67 CATARACT NUCLEAR 6 0.0090
68 MUCOSAL EROSION 8 0.0088
69 HYPERPARATHYROIDISM SECONDARY 22 0.0088
70 TENDONITIS 130 0.0084
71 VITREOUS OPACITIES 7 0.0083
72 KERATITIS 25 0.0082
73 CROSS SENSITIVITY REACTION 8 0.0082
74 SMALL FIBRE NEUROPATHY 6 0.0081
75 ENDOCRINE OPHTHALMOPATHY 7 0.0081
76 PERIODONTAL DISEASE 11 0.0078
77 NEPHROGENIC ANAEMIA 36 0.0078
78 DIARRHOEA INFECTIOUS 6 0.0076
79 EXTENSOR PLANTAR RESPONSE 7 0.0076
80 VITRITIS 14 0.0076
81 CORNEAL ABRASION 10 0.0073
82 COARCTATION OF THE AORTA 7 0.0072
83 ACQUIRED HAEMOPHILIA 7 0.0070
84 RASH MORBILLIFORM 19 0.0068
85 MOTION SICKNESS 13 0.0067
86 EYE PAIN 374 0.0066
87 CYTOLYTIC HEPATITIS 22 0.0066
88 ORCHITIS 7 0.0065
89 EYELID IRRITATION 16 0.0064
90 OSTEITIS 16 0.0063
91 HYPERMETROPIA 6 0.0063
92 OTORRHOEA 11 0.0063
93 RETINAL OEDEMA 12 0.0063
94 SCLERITIS 10 0.0062
95 EYE INFLAMMATION 59 0.0062
96 RETINAL DEGENERATION 8 0.0062
97 ILLUSION 10 0.0060
98 METAMORPHOPSIA 11 0.0060
99 TYMPANIC MEMBRANE PERFORATION 10 0.0059
100 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
101 DYSAESTHESIA 18 0.0059
102 CONJUNCTIVAL OEDEMA 6 0.0058
103 FIXED ERUPTION 10 0.0058
104 VITREOUS HAEMORRHAGE 16 0.0058
105 ATROPHY 11 0.0056
106 OCULAR DISCOMFORT 63 0.0056
107 NECROTISING COLITIS 7 0.0055
108 FOREIGN BODY SENSATION IN EYES 35 0.0055
109 IMMUNE RECONSTITUTION SYNDROME 7 0.0054
110 TENDON INJURY 20 0.0054
111 TESTICULAR PAIN 17 0.0054
112 SUPERINFECTION 8 0.0053
113 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
114 PERIODONTITIS 11 0.0051
115 PHOTOPHOBIA 95 0.0050
116 CUTANEOUS VASCULITIS 18 0.0049
117 RENAL ATROPHY 6 0.0048
118 CONJUNCTIVITIS ALLERGIC 7 0.0047
119 DACRYOSTENOSIS ACQUIRED 6 0.0046
120 ASTIGMATISM 7 0.0046
121 SWELLING OF EYELID 29 0.0046
122 HENOCH-SCHONLEIN PURPURA 10 0.0046
123 HYPERACUSIS 17 0.0046
124 MULTIPLE-DRUG RESISTANCE 14 0.0045
125 EAR HAEMORRHAGE 9 0.0044
126 EYE INFECTION 50 0.0044
127 OTOTOXICITY 8 0.0043
128 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
129 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
130 IRIDOCYCLITIS 13 0.0041
131 BICYTOPENIA 8 0.0041
132 HYPERAEMIA 8 0.0041
133 TENDON RUPTURE 50 0.0040
134 HALLUCINATIONS, MIXED 17 0.0040
135 PERSECUTORY DELUSION 10 0.0040
136 TENOSYNOVITIS 11 0.0040
137 HEPATOSPLENOMEGALY 10 0.0039
138 ESSENTIAL HYPERTENSION 7 0.0038
139 EYELID MARGIN CRUSTING 11 0.0038
140 PUSTULE 9 0.0038
141 EYE DISCHARGE 39 0.0037
142 BLEPHARITIS 15 0.0037
143 WEIGHT BEARING DIFFICULTY 10 0.0037
144 EYE OPERATION 17 0.0037
145 INTRAOCULAR PRESSURE INCREASED 47 0.0037
146 RENAL TUBULAR ACIDOSIS 8 0.0037
147 OCULAR HYPERTENSION 7 0.0036
148 PSEUDOMEMBRANOUS COLITIS 8 0.0036
149 PYELONEPHRITIS ACUTE 7 0.0036
150 TOXIC SKIN ERUPTION 35 0.0035
151 EYELID DISORDER 8 0.0035
152 PYELONEPHRITIS 30 0.0035
153 VITREOUS FLOATERS 34 0.0035
154 PRODUCT PACKAGING DIFFICULT TO OPEN 9 0.0034
155 MACULAR OEDEMA 19 0.0034
156 CONJUNCTIVAL HYPERAEMIA 12 0.0034
157 LIVER TRANSPLANT REJECTION 6 0.0033
158 MUSCLE RUPTURE 13 0.0033
159 CARTILAGE INJURY 8 0.0032
160 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 25 0.0032
161 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 16 0.0032
162 ECCHYMOSIS 22 0.0032
163 DERMATITIS EXFOLIATIVE 16 0.0032
164 CEREBELLAR SYNDROME 7 0.0032
165 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
166 HYPOREFLEXIA 6 0.0031
167 HEPATIC CYTOLYSIS 39 0.0031
168 JOINT NOISE 6 0.0031
169 NECROSIS 17 0.0031
170 PURPURA 27 0.0030
171 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 6 0.0030
172 EYE IRRITATION 173 0.0030
173 FOOD INTOLERANCE 11 0.0030
174 CHOLESTASIS 57 0.0030
175 END STAGE RENAL DISEASE 54 0.0030
176 LACRIMATION INCREASED 88 0.0029
177 ELECTRIC SHOCK SENSATION 8 0.0029
178 CONJUNCTIVITIS 53 0.0029
179 RETINAL TEAR 7 0.0028
180 HORDEOLUM 12 0.0028
181 ERYTHEMA OF EYELID 15 0.0028
182 ESCHERICHIA SEPSIS 8 0.0028
183 STRABISMUS 8 0.0027
184 NEURALGIA 66 0.0027
185 RETINAL DISORDER 7 0.0027
186 AGRANULOCYTOSIS 50 0.0027
187 MENINGITIS ASEPTIC 12 0.0027
188 MUSCLE ATROPHY 33 0.0026
189 BILIRUBIN CONJUGATED INCREASED 6 0.0026
190 TYPE I HYPERSENSITIVITY 9 0.0026
191 CHRONIC KIDNEY DISEASE 194 0.0026
192 PATHOGEN RESISTANCE 23 0.0025
193 IMMOBILE 11 0.0025
194 DERMATITIS BULLOUS 18 0.0025
195 SKIN EROSION 8 0.0025
196 PERIORBITAL SWELLING 14 0.0025
197 EYE SWELLING 92 0.0025
198 HAEMOLYTIC ANAEMIA 22 0.0025
199 SKIN HYPERPIGMENTATION 21 0.0024
200 VASCULAR DEVICE INFECTION 11 0.0024
201 OTITIS MEDIA 8 0.0024
202 AORTIC DISSECTION 10 0.0024
203 NEGATIVE THOUGHTS 7 0.0024
204 STEVENS-JOHNSON SYNDROME 53 0.0024
205 SLEEP TERROR 10 0.0024
206 DRUG RESISTANCE 61 0.0024
207 EXCORIATION 6 0.0024
208 OCULAR HYPERAEMIA 112 0.0024
209 HYPERTHERMIA 18 0.0024
210 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
211 BLINDNESS UNILATERAL 33 0.0023
212 RASH MACULO-PAPULAR 51 0.0023
213 INTERNATIONAL NORMALISED RATIO INCREASED 65 0.0023
214 OESOPHAGEAL CANDIDIASIS 9 0.0023
215 AREFLEXIA 6 0.0022
216 HAEMORRHAGIC DIATHESIS 8 0.0022
217 RETINAL HAEMORRHAGE 16 0.0022
218 EOSINOPHILIA 39 0.0022
219 INFUSION SITE PRURITUS 7 0.0022
220 PANIC REACTION 16 0.0022
221 PHOTOPSIA 14 0.0022
222 CATARACT OPERATION 13 0.0022
223 RETINAL DETACHMENT 20 0.0022
224 HEPATITIS ACUTE 14 0.0022
225 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55 0.0021
226 WRONG DRUG ADMINISTERED 19 0.0021
227 CHRONIC SINUSITIS 8 0.0021
228 DEAFNESS NEUROSENSORY 7 0.0021
229 HEPATOCELLULAR INJURY 30 0.0021
230 OESOPHAGEAL STENOSIS 6 0.0021
231 VISUAL ACUITY REDUCED 70 0.0021
232 EAR INFECTION 56 0.0021
233 CATARACT 125 0.0021
234 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
235 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
236 ENCEPHALOPATHY 51 0.0021
237 ORAL CANDIDIASIS 27 0.0020
238 EAR DISCOMFORT 21 0.0020
239 ANHEDONIA 53 0.0020
240 PATENT DUCTUS ARTERIOSUS 8 0.0020
241 HEPATITIS CHOLESTATIC 12 0.0020
242 ECONOMIC PROBLEM 30 0.0020
243 IRITIS 6 0.0020
244 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
245 LOCALISED OEDEMA 9 0.0019
246 ABNORMAL LOSS OF WEIGHT 13 0.0019
247 FACIAL PAIN 17 0.0019
248 BLADDER PAIN 6 0.0019
249 PULMONARY TUBERCULOSIS 8 0.0019
250 ABNORMAL SENSATION IN EYE 8 0.0019
251 PRODUCT DELIVERY MECHANISM ISSUE 10 0.0019
252 ASPHYXIA 15 0.0018
253 PRODUCT ADMINISTRATION ERROR 37 0.0018
254 TONGUE DISCOLOURATION 8 0.0018
255 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
256 TINNITUS 83 0.0018
257 INTRACRANIAL PRESSURE INCREASED 10 0.0018
258 POST-TRAUMATIC STRESS DISORDER 12 0.0018
259 PLANTAR FASCIITIS 6 0.0018
260 RECALLED PRODUCT ADMINISTERED 17 0.0018
261 HEPATIC FIBROSIS 6 0.0017
262 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
263 HERPES VIRUS INFECTION 10 0.0017
264 HYPERREFLEXIA 6 0.0017
265 HYPERTRIGLYCERIDAEMIA 10 0.0017
266 ESCHERICHIA INFECTION 14 0.0017
267 HEPATITIS 43 0.0017
268 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
269 HYDROCEPHALUS 9 0.0017
270 FEBRILE BONE MARROW APLASIA 7 0.0016
271 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
272 JAW DISORDER 9 0.0016
273 PARADOXICAL DRUG REACTION 6 0.0016
274 ACUTE KIDNEY INJURY 248 0.0016
275 RENAL FAILURE 213 0.0016
276 EAR PAIN 31 0.0016
277 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
278 CARDIAC VALVE DISEASE 9 0.0016
279 MYOSITIS 14 0.0016
280 LYMPHOPENIA 22 0.0016
281 CACHEXIA 8 0.0016
282 EYELID OEDEMA 18 0.0015
283 FACE OEDEMA 26 0.0015
284 SYNOVIAL CYST 7 0.0015
285 MYOCLONUS 18 0.0015
286 RENAL FAILURE ACUTE 63 0.0015
287 SKIN ABRASION 7 0.0015
288 SHOCK HAEMORRHAGIC 12 0.0015
289 ARTHRITIS BACTERIAL 6 0.0015
290 HYPERURICAEMIA 6 0.0015
291 PIGMENTATION DISORDER 9 0.0015
292 ASTHENOPIA 8 0.0015
293 GLAUCOMA 28 0.0015
294 MULTI-ORGAN FAILURE 25 0.0014
295 ENCEPHALITIS 10 0.0014
296 FORMICATION 10 0.0014
297 DRY EYE 71 0.0014
298 POLYNEUROPATHY 17 0.0014
299 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
300 DIVERTICULUM 10 0.0014
301 HYPOTONIA 14 0.0014
302 NEUROLOGICAL SYMPTOM 8 0.0014
303 HERPES SIMPLEX 9 0.0014
304 OCULAR ICTERUS 6 0.0014
305 TRANSPLANT REJECTION 11 0.0014
306 DIVERTICULUM INTESTINAL 6 0.0014
307 ASPERGILLUS INFECTION 9 0.0014
308 PARONYCHIA 6 0.0014
309 RHINITIS 11 0.0014
310 BLINDNESS TRANSIENT 10 0.0014
311 HAEMATOMA 35 0.0013
312 SKIN NECROSIS 7 0.0013
313 SKIN MASS 9 0.0013
314 PLEURISY 8 0.0013
315 MUSCLE TWITCHING 31 0.0013
316 PETECHIAE 14 0.0013
317 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
318 HEPATOMEGALY 13 0.0013
319 EXTRASYSTOLES 9 0.0013
320 PRODUCT CONTAINER ISSUE 11 0.0013
321 MUSCULOSKELETAL DISCOMFORT 22 0.0013
322 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
323 HYPERKERATOSIS 7 0.0013
324 STREPTOCOCCAL INFECTION 7 0.0013
325 VISION BLURRED 172 0.0013
326 MALNUTRITION 14 0.0013
327 KIDNEY TRANSPLANT REJECTION 6 0.0012
328 PRODUCT LEAKAGE 7 0.0012
329 VISUAL FIELD DEFECT 9 0.0012
330 CANDIDA INFECTION 21 0.0012
331 STAPHYLOCOCCAL INFECTION 41 0.0012
332 PANIC ATTACK 45 0.0012
333 GASTROENTERITIS 18 0.0012
334 EXERCISE TOLERANCE DECREASED 7 0.0012
335 BLINDNESS 49 0.0012
336 EYE HAEMORRHAGE 16 0.0012
337 HALLUCINATION, AUDITORY 19 0.0012
338 VISUAL IMPAIRMENT 147 0.0012
339 TOXIC ENCEPHALOPATHY 6 0.0012
340 BACTERAEMIA 14 0.0012
341 PETIT MAL EPILEPSY 6 0.0012
342 PROTHROMBIN TIME PROLONGED 7 0.0012
343 ANURIA 10 0.0012
344 MULTIPLE ALLERGIES 9 0.0011
345 PARTIAL SEIZURES 6 0.0011
346 GROIN PAIN 10 0.0011
347 PAPULE 8 0.0011
348 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
349 GENERALISED OEDEMA 14 0.0011
350 DRUG ERUPTION 20 0.0011
351 VITAMIN D DEFICIENCY 11 0.0011
352 ORAL HERPES 22 0.0011
353 SEPTIC SHOCK 49 0.0011
354 IMPAIRED WORK ABILITY 24 0.0011
355 OSTEOPENIA 17 0.0011
356 MEDICATION ERROR 62 0.0011
357 DRUG DISPENSING ERROR 17 0.0011
358 STRESS FRACTURE 6 0.0011
359 MUSCLE DISORDER 9 0.0011
360 HAEMATURIA 38 0.0011
361 BLOOD URINE PRESENT 21 0.0011
362 ACUTE HEPATIC FAILURE 15 0.0011
363 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
364 MUSCLE INJURY 9 0.0011
365 NERVE INJURY 12 0.0011
366 ATRIAL SEPTAL DEFECT 9 0.0011
367 ACUTE PULMONARY OEDEMA 6 0.0011
368 STATUS EPILEPTICUS 12 0.0011
369 PAROSMIA 8 0.0011
370 SEASONAL ALLERGY 15 0.0011
371 SKIN LESION 29 0.0011
372 DERMATITIS CONTACT 12 0.0011
373 PSEUDOMONAS INFECTION 9 0.0010
374 SLEEP APNOEA SYNDROME 20 0.0010
375 LIPASE INCREASED 8 0.0010
376 EYE PRURITUS 35 0.0010
377 NEUROPATHY PERIPHERAL 99 0.0010
378 ENTEROCOLITIS 6 0.0010
379 PANCYTOPENIA 58 0.0010
380 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
381 TRANSAMINASES INCREASED 23 0.0010
382 HYPOALBUMINAEMIA 8 0.0010
383 APATHY 15 0.0010
384 RASH PAPULAR 23 0.0010
385 TUMOUR LYSIS SYNDROME 9 0.0010
386 RIB FRACTURE 21 0.0010
387 PRODUCT USE COMPLAINT 16 0.0010
388 NASAL DISCOMFORT 8 0.0010
389 INFUSION SITE PAIN 13 0.0010
390 BLOOD ALBUMIN DECREASED 8 0.0010
391 HYPERTRANSAMINASAEMIA 7 0.0010
392 HYPERLIPIDAEMIA 12 0.0010
393 EYE DISORDER 33 0.0010
394 NERVOUS SYSTEM DISORDER 31 0.0010
395 OPTIC NEURITIS 9 0.0010
396 ADRENAL INSUFFICIENCY 12 0.0010
397 FIBROMYALGIA 24 0.0010
398 EYELID PTOSIS 10 0.0010
399 POST PROCEDURAL INFECTION 8 0.0010
400 GRAFT VERSUS HOST DISEASE 7 0.0010
401 OSTEONECROSIS OF JAW 24 0.0010
402 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
403 UVEITIS 13 0.0010
404 DRUG TOXICITY 13 0.0010
405 INFUSION SITE SWELLING 6 0.0010
406 DRUG INTERACTION 150 0.0009
407 ARTHROPOD BITE 7 0.0009
408 RESPIRATORY DISTRESS 26 0.0009
409 PULMONARY MASS 14 0.0009
410 HYPERCHOLESTEROLAEMIA 9 0.0009
411 THROMBOCYTOPENIA 103 0.0009
412 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
413 IMPAIRED HEALING 30 0.0009
414 HYPOGAMMAGLOBULINAEMIA 6 0.0009
415 SPINAL OSTEOARTHRITIS 8 0.0009
416 PHOTOSENSITIVITY REACTION 15 0.0009
417 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
418 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
419 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
420 HALLUCINATION, VISUAL 19 0.0009
421 SALIVARY HYPERSECRETION 9 0.0009
422 BRAIN FOG 14 0.0009
423 CYANOSIS 14 0.0009
424 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
425 TRICUSPID VALVE INCOMPETENCE 7 0.0009
426 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
427 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
428 HYPERBILIRUBINAEMIA 9 0.0009
429 CARDIO-RESPIRATORY ARREST 36 0.0009
430 DECUBITUS ULCER 7 0.0009
431 NECK PAIN 48 0.0009
432 NEPHROPATHY 8 0.0009
433 JAUNDICE 23 0.0009
434 OSTEOARTHRITIS 36 0.0008
435 DRUG LEVEL INCREASED 14 0.0008
436 PANCREATITIS ACUTE 19 0.0008
437 JOINT INJURY 18 0.0008
438 LEUKOPENIA 42 0.0008
439 DELUSION 13 0.0008
440 PULMONARY CONGESTION 11 0.0008
441 PARAESTHESIA ORAL 12 0.0008
442 MYALGIA 141 0.0008
443 ATELECTASIS 8 0.0008
444 BURNING SENSATION 58 0.0008
445 RASH PUSTULAR 6 0.0008
446 LYMPHADENOPATHY 29 0.0008
447 CONFUSIONAL STATE 132 0.0008
448 RENAL TUBULAR NECROSIS 8 0.0008
449 DENTAL CARIES 9 0.0008
450 BLOOD MAGNESIUM DECREASED 7 0.0008
451 URINARY INCONTINENCE 24 0.0008
452 ORAL PAIN 18 0.0008
453 ANAEMIA 152 0.0008
454 EMPHYSEMA 8 0.0008
455 MUSCULAR WEAKNESS 90 0.0008
456 ACIDOSIS 6 0.0008
457 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
458 GASTROINTESTINAL INFECTION 7 0.0008
459 MYDRIASIS 10 0.0008
460 ANAL INCONTINENCE 7 0.0008
461 THROAT TIGHTNESS 21 0.0008
462 PARAESTHESIA 122 0.0008
463 MADAROSIS 9 0.0008
464 DIALYSIS 11 0.0008
465 HIATUS HERNIA 10 0.0008
466 VERTIGO 47 0.0008
467 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
468 ANXIETY 216 0.0008
469 GRAND MAL CONVULSION 7 0.0008
470 INCONTINENCE 8 0.0008
471 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
472 RENAL CYST 6 0.0008
473 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
474 HEPATIC ENCEPHALOPATHY 7 0.0007
475 HYPERKALAEMIA 26 0.0007
476 ANAPHYLACTIC SHOCK 19 0.0007
477 DIPLOPIA 19 0.0007
478 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 35 0.0007
479 ANGIOEDEMA 32 0.0007
480 CYTOMEGALOVIRUS INFECTION 12 0.0007
481 URINARY TRACT INFECTION 123 0.0007
482 SECRETION DISCHARGE 9 0.0007
483 INFLAMMATION 37 0.0007
484 DEMENTIA 20 0.0007
485 PHARYNGEAL SWELLING 7 0.0007
486 RASH MACULAR 25 0.0007
487 LUNG DISORDER 35 0.0007
488 SKIN INFECTION 8 0.0007
489 SENSATION OF FOREIGN BODY 6 0.0007
490 LUNG INFECTION 11 0.0007
491 EJECTION FRACTION DECREASED 11 0.0007
492 MITRAL VALVE INCOMPETENCE 8 0.0007
493 NEUTROPENIA 96 0.0007
494 PAIN IN JAW 20 0.0007
495 SINUS TACHYCARDIA 10 0.0007
496 FACIAL PARALYSIS 6 0.0007
497 MYOCARDIAL ISCHAEMIA 8 0.0007
498 SCAB 8 0.0007
499 DRUG-INDUCED LIVER INJURY 22 0.0007
500 THERAPY INTERRUPTED 50 0.0007
501 ANOREXIA 9 0.0007
502 HEPATIC STEATOSIS 13 0.0007
503 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
504 MUSCLE STRAIN 6 0.0007
505 MYELODYSPLASTIC SYNDROME 10 0.0007
506 PLATELET COUNT INCREASED 9 0.0007
507 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
508 BRONCHITIS 51 0.0007
509 DEAFNESS 18 0.0007
510 URINE OUTPUT DECREASED 6 0.0007
511 BEDRIDDEN 9 0.0007
512 GASTRIC ULCER 13 0.0007
513 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
514 MUSCULOSKELETAL DISORDER 13 0.0007
515 DISORIENTATION 27 0.0007
516 AGITATION 50 0.0007
517 LUNG INFILTRATION 6 0.0007
518 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
519 ACUTE RESPIRATORY FAILURE 13 0.0007
520 PALPITATIONS 79 0.0007
521 MANIA 11 0.0007
522 BLOOD BILIRUBIN INCREASED 18 0.0007
523 ANGINA PECTORIS 19 0.0007
524 RENAL PAIN 7 0.0007
525 IMPAIRED GASTRIC EMPTYING 9 0.0007
526 FUNGAL INFECTION 22 0.0007
527 BURSITIS 8 0.0007
528 GENERAL PHYSICAL HEALTH DETERIORATION 76 0.0007
529 PNEUMONIA BACTERIAL 6 0.0007
530 HIP FRACTURE 21 0.0007
531 SLEEP DISORDER 46 0.0007
532 DEVICE RELATED INFECTION 10 0.0006
533 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
534 GASTRITIS 17 0.0006
535 FULL BLOOD COUNT DECREASED 13 0.0006
536 CARPAL TUNNEL SYNDROME 9 0.0006
537 SCAR 11 0.0006
538 DIARRHOEA HAEMORRHAGIC 6 0.0006
539 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
540 THERAPY PARTIAL RESPONDER 10 0.0006
541 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
542 FLANK PAIN 6 0.0006
543 BONE MARROW FAILURE 13 0.0006
544 COLITIS 24 0.0006
545 SPUTUM DISCOLOURED 6 0.0006
546 DYSPHAGIA 60 0.0006
547 DISTURBANCE IN ATTENTION 34 0.0006
548 TACHYCARDIA 56 0.0006
549 ARTHRALGIA 262 0.0006
550 APHASIA 19 0.0006
551 DEVICE USE ISSUE 11 0.0006
552 SCIATICA 10 0.0006
553 IMPAIRED QUALITY OF LIFE 9 0.0006
554 HALLUCINATION 47 0.0006
555 SENSORY DISTURBANCE 10 0.0006
556 ROTATOR CUFF SYNDROME 8 0.0006
557 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
558 ANOSMIA 9 0.0006
559 SINUS BRADYCARDIA 6 0.0006
560 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
561 PYREXIA 213 0.0006
562 CHOKING 12 0.0006
563 SINUSITIS 63 0.0006
564 GASTROINTESTINAL DISORDER 55 0.0006
565 MENTAL STATUS CHANGES 17 0.0006
566 BODY TEMPERATURE DECREASED 6 0.0006
567 PERICARDIAL EFFUSION 14 0.0006
568 CONDITION AGGRAVATED 184 0.0006
569 EXTRAPYRAMIDAL DISORDER 15 0.0006
570 BONE DISORDER 11 0.0006
571 ELECTROLYTE IMBALANCE 7 0.0006
572 DEPRESSION 137 0.0006
573 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
574 SKIN DISORDER 20 0.0006
575 ARTHRITIS 47 0.0006
576 SEPSIS 66 0.0006
577 PLEURAL EFFUSION 36 0.0006
578 HYPOAESTHESIA 88 0.0006
579 MACULAR DEGENERATION 7 0.0006
580 RASH ERYTHEMATOUS 28 0.0006
581 MUSCLE RIGIDITY 7 0.0006
582 INITIAL INSOMNIA 6 0.0006
583 MUSCULOSKELETAL CHEST PAIN 9 0.0006
584 TEMPERATURE INTOLERANCE 6 0.0006
585 SKIN ULCER 15 0.0006
586 POOR VENOUS ACCESS 6 0.0006
587 PROTEINURIA 11 0.0006
588 NOCTURIA 7 0.0006
589 ARTHROPATHY 32 0.0006
590 BONE DENSITY DECREASED 18 0.0006
591 MENTAL DISORDER 25 0.0006
592 COORDINATION ABNORMAL 8 0.0006
593 CARDIAC FAILURE 46 0.0006
594 MASS 8 0.0006
595 RENAL INJURY 17 0.0006
596 CYTOPENIA 7 0.0006
597 NEUROTOXICITY 10 0.0006
598 DEPRESSED MOOD 30 0.0006
599 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
600 HEAD DISCOMFORT 10 0.0006
601 PHARYNGITIS 7 0.0006
602 HEPATIC FAILURE 17 0.0006
603 INSOMNIA 150 0.0006
604 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
605 AGEUSIA 14 0.0006
606 ISCHAEMIC STROKE 10 0.0006
607 INFECTION 81 0.0006
608 CONVULSION 32 0.0006
609 PARALYSIS 8 0.0006
610 DYSARTHRIA 21 0.0006
611 FEAR 15 0.0006
612 DERMATITIS ALLERGIC 7 0.0006
613 DISABILITY 11 0.0006
614 THERAPY NON-RESPONDER 25 0.0006
615 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
616 MUSCLE TIGHTNESS 9 0.0006
617 PHARYNGITIS STREPTOCOCCAL 6 0.0006
618 MUSCULOSKELETAL PAIN 29 0.0006
619 EMOTIONAL DISTRESS 67 0.0006
620 OSTEOMYELITIS 10 0.0006
621 SKIN LACERATION 6 0.0006
622 PALLOR 15 0.0006
623 PNEUMONITIS 15 0.0006
624 HYPONATRAEMIA 31 0.0005
625 OESOPHAGITIS 6 0.0005
626 ARRHYTHMIA 26 0.0005
627 DELIRIUM 19 0.0005
628 SURGERY 32 0.0005
629 GASTROINTESTINAL PAIN 6 0.0005
630 TOOTH FRACTURE 6 0.0005
631 TREATMENT FAILURE 45 0.0005
632 FOOT DEFORMITY 6 0.0005
633 RESPIRATORY TRACT INFECTION 14 0.0005
634 BLOOD UREA INCREASED 9 0.0005
635 RENAL DISORDER 25 0.0005
636 MUSCULOSKELETAL STIFFNESS 47 0.0005
637 NODULE 7 0.0005
638 RENAL IMPAIRMENT 45 0.0005
639 OSTEOPOROSIS 22 0.0005
640 SPEECH DISORDER 28 0.0005
641 BLOOD POTASSIUM DECREASED 16 0.0005
642 BACK PAIN 123 0.0005
643 COMA 25 0.0005
644 DERMATITIS 11 0.0005
645 LACTIC ACIDOSIS 17 0.0005
646 PRODUCTIVE COUGH 25 0.0005
647 EPILEPSY 16 0.0005
648 C-REACTIVE PROTEIN INCREASED 19 0.0005
649 PARANOIA 9 0.0005
650 MOUTH ULCERATION 11 0.0005
651 SHOCK 12 0.0005
652 EPISTAXIS 39 0.0005
653 METASTASES TO LUNG 6 0.0005
654 SINUS CONGESTION 7 0.0005
655 OEDEMA 28 0.0005
656 PAIN IN EXTREMITY 152 0.0005
657 LIMB INJURY 14 0.0005
658 COGNITIVE DISORDER 24 0.0005
659 DYSSTASIA 15 0.0005
660 RHINORRHOEA 33 0.0005
661 PRODUCT DOSE OMISSION ISSUE 150 0.0005
662 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
663 HEPATIC FUNCTION ABNORMAL 19 0.0005
664 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
665 BLOOD CREATININE INCREASED 33 0.0005
666 SINUS DISORDER 10 0.0005
667 HERPES ZOSTER 29 0.0005
668 DYSPNOEA EXERTIONAL 19 0.0005
669 CHOLECYSTITIS 6 0.0005
670 HYPOTHYROIDISM 16 0.0005
671 OEDEMA PERIPHERAL 61 0.0005
672 GASTROENTERITIS VIRAL 9 0.0005
673 HYPOKALAEMIA 23 0.0005
674 SKIN REACTION 7 0.0005
675 TOOTH DISORDER 11 0.0005
676 HEPATOTOXICITY 11 0.0005
677 TREATMENT NONCOMPLIANCE 27 0.0005
678 BLOOD POTASSIUM INCREASED 8 0.0005
679 BRONCHOSPASM 7 0.0005
680 DYSURIA 18 0.0005
681 MUSCLE SPASTICITY 6 0.0005
682 CARDIOMEGALY 6 0.0005
683 HYPERCALCAEMIA 6 0.0005
684 LIMB DISCOMFORT 15 0.0005
685 FEMUR FRACTURE 15 0.0005
686 HEART RATE DECREASED 17 0.0005
687 ILEUS 6 0.0005
688 HYPOKINESIA 7 0.0005
689 VIRAL INFECTION 16 0.0005
690 BLISTER 27 0.0005
691 PNEUMONIA ASPIRATION 12 0.0005
692 NEPHROLITHIASIS 22 0.0005
693 RHABDOMYOLYSIS 20 0.0005
694 GAIT INABILITY 16 0.0005
695 FOOT FRACTURE 9 0.0005
696 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
697 CARDIOMYOPATHY 7 0.0005
698 SKIN HAEMORRHAGE 7 0.0005
699 ANAPHYLACTIC REACTION 26 0.0005
700 HEADACHE 295 0.0005
701 SUICIDAL IDEATION 43 0.0005
702 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
703 DIVERTICULITIS 13 0.0005
704 ERYTHEMA 96 0.0005
705 PNEUMONIA 151 0.0005
706 HYPOACUSIS 20 0.0005
707 OXYGEN SATURATION DECREASED 26 0.0005
708 CORONARY ARTERY DISEASE 14 0.0005
709 ATRIAL FIBRILLATION 45 0.0005
710 THERAPEUTIC RESPONSE DECREASED 28 0.0005
711 PRODUCT PRESCRIBING ERROR 11 0.0005
712 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
713 HAEMORRHOIDS 9 0.0005
714 BONE PAIN 27 0.0005
715 SWELLING FACE 30 0.0005
716 ORTHOSTATIC HYPOTENSION 8 0.0005
717 MUSCLE SPASMS 84 0.0005
718 CHOLELITHIASIS 15 0.0005
719 INTENTIONAL DOSE OMISSION 13 0.0005
720 INTERSTITIAL LUNG DISEASE 22 0.0005
721 HYPOXIA 16 0.0005
722 PAIN 279 0.0005
723 RESPIRATORY FAILURE 33 0.0005
724 BRADYCARDIA 24 0.0005
725 PRESYNCOPE 11 0.0005
726 FLUID RETENTION 23 0.0005
727 TREMOR 75 0.0005
728 INTESTINAL OBSTRUCTION 17 0.0005
729 ACUTE MYELOID LEUKAEMIA 7 0.0004
730 SWOLLEN TONGUE 14 0.0004
731 LIVER INJURY 11 0.0004
732 MEMORY IMPAIRMENT 61 0.0004
733 NO ADVERSE EVENT 80 0.0004
734 CYSTITIS 14 0.0004
735 OBESITY 7 0.0004
736 GAIT DISTURBANCE 84 0.0004
737 ABSCESS 7 0.0004
738 ACCIDENTAL OVERDOSE 16 0.0004
739 CARDIAC ARREST 36 0.0004
740 URTICARIA 73 0.0004
741 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
742 RESPIRATORY DISORDER 13 0.0004
743 HYPERTENSION 92 0.0004
744 HYPOGLYCAEMIA 21 0.0004
745 INFLUENZA 48 0.0004
746 ABDOMINAL PAIN 100 0.0004
747 METASTASES TO BONE 7 0.0004
748 BLOOD SODIUM DECREASED 8 0.0004
749 PULMONARY OEDEMA 19 0.0004
750 SEIZURE 49 0.0004
751 VENTRICULAR TACHYCARDIA 7 0.0004
752 WHEEZING 25 0.0004
753 DYSKINESIA 17 0.0004
754 DYSGEUSIA 31 0.0004
755 BALANCE DISORDER 36 0.0004
756 LOWER LIMB FRACTURE 8 0.0004
757 HYPERTHYROIDISM 6 0.0004
758 PRODUCT DOSE OMISSION 27 0.0004
759 ASTHENIA 155 0.0004
760 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
761 DYSPHONIA 24 0.0004
762 CHEST PAIN 76 0.0004
763 RESTLESSNESS 15 0.0004
764 MELAENA 9 0.0004
765 FALL 136 0.0004
766 ILLNESS 42 0.0004
767 METABOLIC ACIDOSIS 13 0.0004
768 PRURITUS 156 0.0004
769 RASH PRURITIC 22 0.0004
770 NIGHTMARE 14 0.0004
771 COUGH 113 0.0004
772 BLOOD PRESSURE ABNORMAL 8 0.0004
773 ECZEMA 21 0.0004
774 CHILLS 47 0.0004
775 LETHARGY 23 0.0004
776 CYTOKINE RELEASE SYNDROME 8 0.0004
777 INJURY 28 0.0004
778 HYPOAESTHESIA ORAL 6 0.0004
779 DEHYDRATION 53 0.0004
780 COLD SWEAT 7 0.0004
781 DIARRHOEA 256 0.0004
782 GASTROINTESTINAL HAEMORRHAGE 33 0.0004
783 HYPERSENSITIVITY 73 0.0004
784 HYPOPHAGIA 10 0.0004
785 HAEMOGLOBIN DECREASED 40 0.0004
786 OROPHARYNGEAL PAIN 36 0.0004
787 LYMPHOMA 6 0.0004
788 TOOTHACHE 7 0.0004
789 PERITONITIS 8 0.0004
790 RASH GENERALISED 10 0.0004
791 PELVIC PAIN 7 0.0004
792 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
793 RASH 165 0.0004
794 EATING DISORDER 8 0.0004
795 DYSPNOEA 211 0.0004
796 WEIGHT DECREASED 104 0.0004
797 NIGHT SWEATS 12 0.0004
798 PERIPHERAL SWELLING 57 0.0004
799 PSORIATIC ARTHROPATHY 15 0.0004
800 PRODUCT DISPENSING ERROR 8 0.0004
801 PRODUCT PRESCRIBING ISSUE 8 0.0004
802 OFF LABEL USE 320 0.0004
803 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 74 0.0004
804 INCORRECT ROUTE OF DRUG ADMINISTRATION 13 0.0004
805 CEREBRAL HAEMORRHAGE 13 0.0004
806 STOMATITIS 22 0.0004
807 FEBRILE NEUTROPENIA 24 0.0004
808 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
809 POLLAKIURIA 15 0.0004
810 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
811 DISEASE RECURRENCE 17 0.0004
812 EMOTIONAL DISORDER 11 0.0004
813 HYPERGLYCAEMIA 13 0.0004
814 SNEEZING 8 0.0004
815 CHROMATURIA 8 0.0004
816 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
817 ABNORMAL BEHAVIOUR 14 0.0004
818 FATIGUE 274 0.0004
819 UNRESPONSIVE TO STIMULI 9 0.0003
820 CONSTIPATION 76 0.0003
821 SKIN DISCOLOURATION 16 0.0003
822 EXPOSURE VIA SKIN CONTACT 9 0.0003
823 NASOPHARYNGITIS 64 0.0003
824 PLATELET COUNT DECREASED 37 0.0003
825 DEVICE ISSUE 31 0.0003
826 ADVERSE DRUG REACTION 31 0.0003
827 FEEDING DISORDER 7 0.0003
828 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
829 HEART RATE INCREASED 34 0.0003
830 BODY TEMPERATURE INCREASED 7 0.0003
831 SWELLING 32 0.0003
832 CHEST DISCOMFORT 35 0.0003
833 METASTASES TO LIVER 6 0.0003
834 DERMATITIS ATOPIC 18 0.0003
835 ASCITES 10 0.0003
836 ACUTE MYOCARDIAL INFARCTION 10 0.0003
837 PSYCHOTIC DISORDER 10 0.0003
838 DEEP VEIN THROMBOSIS 22 0.0003
839 TOOTH LOSS 7 0.0003
840 COVID-19 59 0.0003
841 CARDIAC FAILURE CONGESTIVE 27 0.0003
842 GALLBLADDER DISORDER 6 0.0003
843 VOMITING 158 0.0003
844 THIRST 6 0.0003
845 MALAISE 147 0.0003
846 BLOOD PRESSURE DECREASED 22 0.0003
847 NAUSEA 261 0.0003
848 DISCOMFORT 20 0.0003
849 PRODUCT USE IN UNAPPROVED INDICATION 81 0.0003
850 PRURITUS GENERALISED 7 0.0003
851 NASAL CONGESTION 19 0.0003
852 DECREASED APPETITE 75 0.0003
853 FAECES DISCOLOURED 7 0.0003
854 HEPATIC ENZYME INCREASED 22 0.0003
855 HAEMOPTYSIS 9 0.0003
856 MOBILITY DECREASED 23 0.0003
857 NEUTROPHIL COUNT DECREASED 13 0.0003
858 CELLULITIS 16 0.0003
859 HYPOCALCAEMIA 6 0.0003
860 ABDOMINAL PAIN LOWER 8 0.0003
861 HAEMATEMESIS 8 0.0003
862 POST PROCEDURAL COMPLICATION 6 0.0003
863 THROAT IRRITATION 14 0.0003
864 CONTUSION 30 0.0003
865 MOVEMENT DISORDER 10 0.0003
866 ERUCTATION 6 0.0003
867 FEELING HOT 19 0.0003
868 LIVER FUNCTION TEST ABNORMAL 9 0.0003
869 HYPOTENSION 62 0.0003
870 BLOOD PRESSURE INCREASED 47 0.0003
871 JOINT SWELLING 37 0.0003
872 KIDNEY INFECTION 6 0.0003
873 MUCOSAL INFLAMMATION 8 0.0003
874 LABORATORY TEST ABNORMAL 9 0.0003
875 JOINT STIFFNESS 8 0.0003
876 PRODUCT USE ISSUE 57 0.0003
877 PANCREATITIS 16 0.0003
878 RECTAL HAEMORRHAGE 13 0.0003
879 UPPER LIMB FRACTURE 6 0.0003
880 PRESCRIBED UNDERDOSE 6 0.0003
881 DIZZINESS 150 0.0003
882 PAIN OF SKIN 8 0.0003
883 PULMONARY EMBOLISM 28 0.0003
884 MOOD ALTERED 8 0.0003
885 MULTIPLE SCLEROSIS 14 0.0003
886 FEELING ABNORMAL 70 0.0003
887 AMNESIA 19 0.0003
888 PRODUCT PREPARATION ERROR 6 0.0003
889 BLOOD GLUCOSE DECREASED 14 0.0003
890 RESPIRATORY ARREST 8 0.0003
891 ABNORMAL DREAMS 8 0.0003
892 CEREBROVASCULAR ACCIDENT 49 0.0003
893 INTENTIONAL PRODUCT MISUSE 25 0.0003
894 ASTHMA 32 0.0003
895 MIGRAINE 27 0.0003
896 IRRITABILITY 17 0.0003
897 ADVERSE EVENT 26 0.0003
898 ILL-DEFINED DISORDER 17 0.0003
899 IRRITABLE BOWEL SYNDROME 6 0.0003
900 DIABETES MELLITUS 21 0.0003
901 NEEDLE ISSUE 8 0.0003
902 ABDOMINAL DISCOMFORT 46 0.0003
903 LOSS OF CONSCIOUSNESS 35 0.0003
904 SKIN EXFOLIATION 23 0.0003
905 DISEASE PROGRESSION 32 0.0003
906 DRUG INEFFECTIVE 356 0.0003
907 SYNCOPE 27 0.0003
908 URINARY RETENTION 9 0.0003
909 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
910 TYPE 2 DIABETES MELLITUS 9 0.0003
911 HOSPITALISATION 41 0.0003
912 HEART RATE IRREGULAR 6 0.0003
913 UNEVALUABLE EVENT 20 0.0003
914 HYPERHIDROSIS 34 0.0003
915 GASTRIC DISORDER 9 0.0003
916 DRUG INTOLERANCE 25 0.0003
917 HAEMORRHAGE 27 0.0003
918 BLOOD CHOLESTEROL INCREASED 12 0.0003
919 INFLUENZA LIKE ILLNESS 21 0.0003
920 DRY SKIN 34 0.0003
921 DEVICE DISLOCATION 11 0.0003
922 FEELING COLD 7 0.0003
923 SKIN BURNING SENSATION 18 0.0003
924 WOUND 7 0.0003
925 TARDIVE DYSKINESIA 7 0.0002
926 LIVER DISORDER 11 0.0002
927 SUICIDE ATTEMPT 15 0.0002
928 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
929 OVERDOSE 53 0.0002
930 CEREBRAL INFARCTION 6 0.0002
931 AGGRESSION 12 0.0002
932 FLUSHING 24 0.0002
933 DYSPEPSIA 23 0.0002
934 ABDOMINAL PAIN UPPER 48 0.0002
935 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
936 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
937 RHEUMATOID ARTHRITIS 26 0.0002
938 COMPLETED SUICIDE 19 0.0002
939 HOT FLUSH 17 0.0002
940 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
941 CARDIAC DISORDER 21 0.0002
942 SOMNOLENCE 45 0.0002
943 ROAD TRAFFIC ACCIDENT 9 0.0002
944 WITHDRAWAL SYNDROME 9 0.0002
945 OSTEONECROSIS 7 0.0002
946 FLATULENCE 12 0.0002
947 THROMBOSIS 17 0.0002
948 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
949 NERVOUSNESS 11 0.0002
950 RED BLOOD CELL COUNT DECREASED 6 0.0002
951 HYPERSOMNIA 6 0.0002
952 ALOPECIA 41 0.0002
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
954 PSORIASIS 27 0.0002
955 TOXICITY TO VARIOUS AGENTS 33 0.0002
956 MYOCARDIAL INFARCTION 34 0.0002
957 DRUG DEPENDENCE 31 0.0002
958 ABDOMINAL DISTENSION 19 0.0002
959 LIP SWELLING 6 0.0002
960 WEIGHT INCREASED 40 0.0002
961 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
962 THERAPY CESSATION 9 0.0002
963 ABORTION SPONTANEOUS 7 0.0002
964 SKIN IRRITATION 8 0.0002
965 DRY MOUTH 14 0.0002
966 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
967 INCORRECT DOSE ADMINISTERED 38 0.0002
968 DRUG EFFECT INCOMPLETE 6 0.0002
969 CRYING 6 0.0002
970 DEATH 141 0.0002
971 PRODUCT STORAGE ERROR 14 0.0002
972 INFUSION RELATED REACTION 10 0.0002
973 UNDERDOSE 11 0.0002
974 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
975 EXPOSURE DURING PREGNANCY 9 0.0001
976 INTENTIONAL OVERDOSE 9 0.0001
977 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
978 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
979 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
980 ACNE 10 0.0001
981 INJECTION SITE SWELLING 10 0.0001
982 INJECTION SITE ERYTHEMA 16 0.0001
983 HAEMATOCHEZIA 7 0.0001
984 NEOPLASM MALIGNANT 8 0.0001
985 BLOOD GLUCOSE INCREASED 21 0.0001
986 PRODUCT QUALITY ISSUE 15 0.0001
987 INJECTION SITE PAIN 27 0.0001
988 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
990 DRUG DOSE OMISSION 13 0.0001
991 INJECTION SITE HAEMORRHAGE 6 0.0001
992 BREAST CANCER 6 0.0001